Evidence map›Paper›PMID 25738413›Full record

ReviewGut microbes2015

Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin.

Kourtney P Nickerson, Rachael Chanin, Christine McDonald

Open access · hybridAbstract readReview
In one paragraph

Review in Gut microbes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Relieving Effect ofAntioxidants (Basel, Switzerland) · 2025
    Article
  19. DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.Digestive diseases and sciences · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Kourtney P Nickersona Mucosal Immunology and Biology Research Center ; Division of Pediatric Gastroenterology and Nutrition ; Massachusetts General Hospital ; Boston , MA USA.
Rachael Chanin
Christine McDonald
Case Western Reserve University · USCenter of Molecular Immunology (Cuba) · CUMassachusetts General Hospital · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Cell interactions in the inflammed intestinal mucosaR01DK050984 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI FIOCCHI, CLAUDIO · 1995 to 2014
$3.1M
Autophagy and Nod2 Function in Crohn's DiseaseR01DK082437 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI MCDONALD, CHRISTINE L · 2009 to 2013
$1.6M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1TR000439NIDDK NIH HHS R01DK050984NIDDK NIH HHS R01 DK082437NIDDK NIH HHS R01DK082437
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a complex, multi-factorial disease thought to arise from an inappropriate immune response to commensal bacteria in a genetically susceptible person that results in chronic, cyclical, intestinal inflammation. Dietary and environmental factors are implicated in the initiation and perpetuation of IBD; however, a singular causative agent has not been identified. As of now, the role of environmental priming or triggers in IBD onset and pathogenesis are not well understood, but these factors appear to synergize with other disease susceptibility factors. In previous work, we determined that the polysaccharide dietary additive, maltodextrin (MDX), impairs cellular anti-bacterial responses and suppresses intestinal anti-microbial defense mechanisms. In this addendum, we review potential mechanisms for dietary deregulation of intestinal homeostasis, postulate how dietary and genetic risk factors may combine to result in disease pathogenesis, and discuss these ideas in the context of recent findings related to dietary interventions for IBD.

Indexed as

AnimalsFood AdditivesHumansImmunity, MucosalImmunosuppressive AgentsInflammatory Bowel DiseasesIntestinal MucosaPolysaccharidesFood AdditivesImmunosuppressive AgentsmaltodextrinPolysaccharidesAIEC, adherent-invasive Escherichia colianti-microbial defenseCD, Crohn's diseaseCMC, carboxymethyl celluloseCrohn's diseasedietdietary additiveDSS, dextran sulfate sodiumFDA, Food and Drug AdministrationGRAS, Generally Recognized As SafeIBD-AID, inflammatory bowel disease-anti-inflammatory dietIBD, inflammatory bowel diseaseinflammatory bowel diseaseintestinal homeostasismaltodextrinMDX, maltodextrinmucosal defenseSCD, specific carbohydrate dietUC, ulcerative colitis

Identifiers

PMID25738413
PMCPMC4615306
OpenAlexW1859278262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.